Karmic Lifesciences exhibits in the 46th DIA Annual Meeting at Washington DC

The 4-day DIA conference was held in Washington DC at the Walter E Washington convention center on June 13-17 2010. The event represents the worlds’ largest assembly of pharmaceutical, biotechnology, CROs and other pharmaceutical service providers. The conference offers the exhibitors to demonstrate their services and capabilities on a global platform with a delegate outreach of 5000+ and over 450 other fellow exhibitors. The convention allows CROs all over the world an attractive dais to network with professionals from Pharma / Biotech and also to explore prospects of strategic partnerships with other CROs from Americas, Europe, Asia, Africa and Australia. Karmic Lifesciences participated in the 46th DIA meeting and strongly showcased its CRO capabilities.

It was rather interesting to see and realize the growing curiosity amongst pharma/biotech professionals to explore India as a promising destination for drug development. It was noteworthy that a majority of pharma/biotechs and many global CROs are now looking at India not just for core CTM but for back office activities like Clinical Data Management, Biostatistics and Medical Writing. There was growing interest observed in industry leaders and decision makers to offshore critical time consuming activities to India owing to the inherent advantages it offers and few even mentioned the prospect of setting up their own operations in India.

Ms Nidhi Saxena, President and CEO of Karmic Lifesciences commented: “It was remarkable to see the rising importance India is gathering as a preferred destination among drug developers and regulators. Our exhibition was a large success for us given the fact that we were visited by hundreds of professionals who were keen to know about our services and capabilities in India. The event has provided us with a generous number of leads and prospects which can be converted into successful partnerships and alliances. We will without doubt exhibit again next year.”

About Karmic Lifesciences: Karmic Lifesciences is a privately funded, ISO 9001:2000 certified and India’s fastest growing full-service CRO with end-to-end offerings in Clinical Trial Management, Clinical Data Management, Bio-Statistics, Medical Writing, Regulatory Submissions/Consulting and Pharmacovigilance. We have a track record of successfully supporting over 40 ICH-GCP compliant clinical studies across multiple therapeutic areas including Oncology, Neurology, Immunology, Cardiovascular, Endocrinology, Ophthalmology, Orthopedics, Respiratory etc. We have a state-of-the-art, 21 CFR part 11 compliant CDM infrastructure with ClinTrial 4.6, Inform EDC, SAS 9.1.3, MedDRA 13.0 and WHO-DD. Our team consists of 40 full-time professionals and 10+ KoLs and Senior Doctors as part of our Medical Advisory Board.